BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

524 related articles for article (PubMed ID: 17626102)

  • 1. Analysis of viral cis elements conferring Kaposi's sarcoma-associated herpesvirus episome partitioning and maintenance.
    Skalsky RL; Hu J; Renne R
    J Virol; 2007 Sep; 81(18):9825-37. PubMed ID: 17626102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kaposi's Sarcoma-Associated Herpesvirus LANA-Adjacent Regions with Distinct Functions in Episome Segregation or Maintenance.
    Juillard F; De León Vázquez E; Tan M; Li S; Kaye KM
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30626680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The minimal replicator element of the Kaposi's sarcoma-associated herpesvirus terminal repeat supports replication in a semiconservative and cell-cycle-dependent manner.
    Verma SC; Choudhuri T; Robertson ES
    J Virol; 2007 Apr; 81(7):3402-13. PubMed ID: 17151118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Kaposi's sarcoma-associated herpesvirus LANA regions important for episome segregation, replication, and persistence.
    Vázquez Ede L; Carey VJ; Kaye KM
    J Virol; 2013 Nov; 87(22):12270-83. PubMed ID: 24006437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus supports latent DNA replication in dividing cells.
    Hu J; Garber AC; Renne R
    J Virol; 2002 Nov; 76(22):11677-87. PubMed ID: 12388727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. H2AX phosphorylation is important for LANA-mediated Kaposi's sarcoma-associated herpesvirus episome persistence.
    Jha HC; Upadhyay SK; A J Prasad M; Lu J; Cai Q; Saha A; Robertson ES
    J Virol; 2013 May; 87(9):5255-69. PubMed ID: 23449797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of Kaposi's Sarcoma-Associated Herpesvirus Latency Using CRISPR-Cas9 To Edit the Latency-Associated Nuclear Antigen Gene.
    Tso FY; West JT; Wood C
    J Virol; 2019 Apr; 93(7):. PubMed ID: 30651362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Full-Length Isoforms of Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Accumulate in the Cytoplasm of Cells Undergoing the Lytic Cycle of Replication.
    Garrigues HJ; Howard K; Barcy S; Ikoma M; Moses AV; Deutsch GH; Wu D; Ueda K; Rose TM
    J Virol; 2017 Dec; 91(24):. PubMed ID: 28978712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus interacts preferentially with the terminal repeats of the genome in vivo and this complex is sufficient for episomal DNA replication.
    Fejér G; Medveczky MM; Horvath E; Lane B; Chang Y; Medveczky PG
    J Gen Virol; 2003 Jun; 84(Pt 6):1451-1462. PubMed ID: 12771414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Latency-associated nuclear antigen (LANA) of Kaposi's sarcoma-associated herpesvirus interacts with origin recognition complexes at the LANA binding sequence within the terminal repeats.
    Verma SC; Choudhuri T; Kaul R; Robertson ES
    J Virol; 2006 Mar; 80(5):2243-56. PubMed ID: 16474132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ORC, MCM, and histone hyperacetylation at the Kaposi's sarcoma-associated herpesvirus latent replication origin.
    Stedman W; Deng Z; Lu F; Lieberman PM
    J Virol; 2004 Nov; 78(22):12566-75. PubMed ID: 15507644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kaposi's sarcoma-associated herpesvirus terminal repeat regulates inducible lytic gene promoters.
    Izumiya Y; Algalil A; Espera JM; Miura H; Izumiya C; Inagaki T; Kumar A
    J Virol; 2024 Feb; 98(2):e0138623. PubMed ID: 38240593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bub1 in Complex with LANA Recruits PCNA To Regulate Kaposi's Sarcoma-Associated Herpesvirus Latent Replication and DNA Translesion Synthesis.
    Sun Z; Jha HC; Robertson ES
    J Virol; 2015 Oct; 89(20):10206-18. PubMed ID: 26223641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kaposi's sarcoma-associated herpesvirus-encoded LANA recruits topoisomerase IIβ for latent DNA replication of the terminal repeats.
    Purushothaman P; McDowell ME; McGuinness J; Salas R; Rumjahn SM; Verma SC
    J Virol; 2012 Sep; 86(18):9983-94. PubMed ID: 22761383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minichromosome Maintenance Proteins Cooperate with LANA during the G
    Dabral P; Uppal T; Rossetto CC; Verma SC
    J Virol; 2019 Apr; 93(7):. PubMed ID: 30651368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ubiquitin-specific protease USP7 modulates the replication of Kaposi's sarcoma-associated herpesvirus latent episomal DNA.
    Jäger W; Santag S; Weidner-Glunde M; Gellermann E; Kati S; Pietrek M; Viejo-Borbolla A; Schulz TF
    J Virol; 2012 Jun; 86(12):6745-57. PubMed ID: 22514345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen modulates K1 expression through its cis-acting elements within the terminal repeats.
    Verma SC; Lan K; Choudhuri T; Robertson ES
    J Virol; 2006 Apr; 80(7):3445-58. PubMed ID: 16537612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LANA oligomeric architecture is essential for KSHV nuclear body formation and viral genome maintenance during latency.
    De Leo A; Deng Z; Vladimirova O; Chen HS; Dheekollu J; Calderon A; Myers KA; Hayden J; Keeney F; Kaufer BB; Yuan Y; Robertson E; Lieberman PM
    PLoS Pathog; 2019 Jan; 15(1):e1007489. PubMed ID: 30682185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Kaposi Sarcoma Herpesvirus Latency-associated Nuclear Antigen DNA Binding Domain Dorsal Positive Electrostatic Patch Facilitates DNA Replication and Episome Persistence.
    Li S; Tan M; Juillard F; Ponnusamy R; Correia B; Simas JP; Carrondo MA; McVey CE; Kaye KM
    J Biol Chem; 2015 Nov; 290(47):28084-28096. PubMed ID: 26420481
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Pires de Miranda M; Quendera AP; McVey CE; Kaye KM; Simas JP
    J Virol; 2018 Nov; 92(21):. PubMed ID: 30111565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.